Calvetti, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 165
EU - Europa 125
AS - Asia 122
SA - Sud America 12
AF - Africa 5
Totale 429
Nazione #
US - Stati Uniti d'America 162
SG - Singapore 52
RU - Federazione Russa 47
CN - Cina 40
GB - Regno Unito 29
HK - Hong Kong 18
IT - Italia 12
BR - Brasile 9
SE - Svezia 9
FR - Francia 7
IE - Irlanda 6
DE - Germania 4
FI - Finlandia 4
KR - Corea 4
NL - Olanda 4
IN - India 3
JP - Giappone 3
MX - Messico 2
TG - Togo 2
AR - Argentina 1
CA - Canada 1
EC - Ecuador 1
GA - Gabon 1
ID - Indonesia 1
LT - Lituania 1
MA - Marocco 1
PT - Portogallo 1
RO - Romania 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 429
Città #
Chandler 28
Southend 27
Singapore 23
Woodbridge 20
Hong Kong 18
Ashburn 15
Dallas 14
New York 11
The Dalles 10
Moscow 9
Beijing 8
Dublin 6
Redondo Beach 4
Chennai 3
Chicago 3
Los Angeles 3
Nanjing 3
Tokyo 3
Washington 3
Belo Horizonte 2
Binasco 2
Cleveland 2
Jinan 2
Lawrence 2
Lomé 2
Marostica 2
Princeton 2
Querétaro 2
Seoul 2
Shanghai 2
Shenyang 2
Turku 2
Wilmington 2
Baie-D'Urfé 1
Barquisimeto 1
Boston 1
Camden 1
Clarksburg 1
Columbus 1
Concord 1
Council Bluffs 1
Fortaleza 1
Frankfurt am Main 1
Fuzhou 1
Guiyang 1
Haikou 1
Humble 1
Ituiutaba 1
Jakarta 1
Johannesburg 1
Kent 1
Libreville 1
Louisville 1
Munich 1
Ningbo 1
Oceanside 1
Portoviejo 1
Saint Louis 1
Salvador 1
Salé 1
San Juan 1
San Mateo 1
Santa Bárbara d'Oeste 1
Santa Clara 1
Schertz 1
Stockholm 1
São João do Ivaí 1
São Paulo 1
Taizhou 1
Tashkent 1
Teixeira de Freitas 1
Tianjin 1
Verona 1
Yicheng 1
Zhengzhou 1
Totale 281
Nome #
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 141
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 113
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG 63
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 61
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 57
Totale 435
Categoria #
all - tutte 1.886
article - articoli 1.886
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 1 0
2021/202221 3 9 0 3 1 0 0 0 0 0 0 5
2022/202352 2 6 2 20 3 8 0 2 2 0 4 3
2023/202449 0 5 8 6 9 15 0 2 0 2 2 0
2024/2025121 6 2 4 30 2 7 5 4 20 16 8 17
2025/2026130 23 12 21 65 9 0 0 0 0 0 0 0
Totale 435